|
04/08/2026 |
Medicine: Loqtorzi toripalimab
|
Updated |
|
04/08/2026 |
Medicine: Silapo epoetin zeta
|
Updated |
|
04/08/2026 |
Medicine: Elmiron pentosan polysulfate sodium
|
Updated |
|
04/08/2026 |
Medicine: Obodence denosumab
|
Updated |
|
04/08/2026 |
Medicine: Bimervax COVID-19 Vaccine (recombinant, adjuvanted)
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Dzuveo sufentanil
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Qinlock ripretinib
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Orphan: EU/3/07/523 - orphan designation for treatment of gastro-entero-pancreatic neuroendocrine tumours Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide (lutetium (177Lu) oxodotreotide)
|
Updated |
|
04/08/2026 |
Orphan: EU/3/25/3118 - orphan designation for treatment of primary hyperoxaluria mRNA encoding Cas12HF endonuclease, Single guide RNA against the human HAO1 gene
|
Updated |
|
04/08/2026 |
Orphan: EU/3/25/3032 - orphan designation for treatment of Olmsted syndrome (R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)pyrrolidin-1-yl)(5-hydroxy-6-methylpyridin-2-yl)methanone
|
Updated |
|
04/08/2026 |
Orphan: EU/3/20/2286 - orphan designation for treatment of soft tissue sarcoma autologous CD4+ and CD8+ T cells transduced with a lentiviral vector encoding an affinity enhanced T cell receptor specific to MAGE-A4
|
Updated |
|
04/08/2026 |
Medicine: SomaKit TOC edotreotide
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
Medicine: Orserdu elacestrant
|
Updated |
|
04/08/2026 |
Medicine: Vitrakvi larotrectinib
|
Updated |
|
04/08/2026 |
Medicine: Skyclarys omaveloxolone
|
Updated |
|
04/08/2026 |
Medicine: Spinraza nusinersen
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Leflunomide medac leflunomide
|
Updated |
|
04/08/2026 |
Medicine: Twinrix Adult hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
04/08/2026 |
Medicine: Orblid bevacizumab
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Orphan: EU/3/16/1694 - orphan designation for treatment of soft tissue sarcoma autologous CD4+ and CD8+ T cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1
|
Updated |
|
04/08/2026 |
|
Updated |
|
03/08/2026 |
Medicine: Vabysmo faricimab
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
Medicine: Takhzyro lanadelumab
|
Updated |
|
03/08/2026 |
Medicine: Lytenava bevacizumab
|
Updated |
|
03/08/2026 |
Medicine: Opzelura ruxolitinib
|
Updated |
|
03/08/2026 |
Medicine: Palsonify paltusotine
|
Updated |
|
03/08/2026 |
Medicine: Ambirix hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
03/08/2026 |
Medicine: Twinrix Paediatric hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |